Validation of the Friedewald Formula in Patients with Metabolic Syndrome

Abstract

Currently, the Friedewald formula (FF) is the main method for evaluating low-density lipoprotein cholesterol (LDL-c). Recently, many limitations have emerged regarding its use, including patients with triglyceride levels ≥400 mg/dL, diabetes mellitus, and kidney or hepatic chronic diseases. We analyzed the use of the FF in patients with metabolic syndrome… (More)
DOI: 10.1155/2014/261878

4 Figures and Tables

Topics

  • Presentations referencing similar topics